Healthcare · Theme
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026
+100
+50
0
−50
−100
Bullish
Bearish
Thu 22
Fri 23
Sat 24
Sun 25
Mon 26
Tue 27
Today
| Day | Score |
|---|---|
| Thu 22 | no data |
| Fri 23 | no data |
| Sat 24 | no data |
| Sun 25 | no data |
| Mon 26 | no data |
| Tue 27 | no data |
| Today | no data |
What this theme is about
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Waters Corporation (NYSE: WAT), a global life sciences and diagnostics leader, today announced a partnership to expand access to the FDA-approved BD Onclarity HPV Assay through Labcorp's nationwide laborato…
Summary drawn from the reporting itself by the Glideslope engine. No AI writing.
- Mood now
- +56.1
- Latest day
- —
- Stories
- 2
- Sources
- 2
Every story in this theme
5 articles, newest first-
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026finance.yahoo.com+76
-
+67
-
Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potentialprnewswire.com0 -
Labcorp Holdings Announces $0.72 Per Share Cash Dividend Payable on December 11, 2026kalkinemedia.com0 -
Labcorp Declares Quarterly Dividendfinance.yahoo.com0
